Literature DB >> 31892011

Fast and sensitive UHPLC-MS/MS analysis of cannabinoids and their acid precursors in pharmaceutical preparations of medical cannabis and their metabolites in conventional and non-conventional biological matrices of treated individual.

Simona Pichini1, Giulio Mannocchi2, Massimo Gottardi3, Ana Pilar Pérez-Acevedo4, Lourdes Poyatos4, Esther Papaseit4, Clara Pérez-Mañá4, Magí Farré4, Roberta Pacifici5, Francesco Paolo Busardò6.   

Abstract

Monitoring pharmacological active compounds in pharmaceutical preparations of medical cannabis and in conventional and non-conventional biological matrices of treated individuals use requires both a wide linear range and sensitive detection. We have developed and validated a fast and sensitive method using ultra-high performance liquid chromatography coupled with tandem mass spectrometry (UHPLC-MS/MS) for analysis of Δ-9-tetrahydrocannabinol (THC), cannabidiol (CBD), their acidic precursors Δ-9-tetrahydrocannabinolic acid A (THCA-A) and cannabidiolic acid (CBDA) and some major metabolites of THC such as 11-nor-9-carboxy-THC (THC-COOH), 11-hydroxy-THC (11-OH-THC), Δ-9-THC-Glucuronide (THC-GLUC) and THC-COOH-Glucuronide (THC-COOH-GLUC) in conventional (whole blood and urine) and non-conventional (oral fluid and sweat) of individual treated with medical cannabis preparation. Specifically, THC, THCA-A, CBD and CBD-A were determined in cannabis decoction and oil prepared to treat individuals. The method used positive electrospray ionization (ESI) mode to reach the sensitivity needed to detect minimal amounts of analytes under investigations exposure with limits of quantification ranging from 0.2 to 0.5 ng per milliliter (ng/mL) or ng per patch in case of collected sweat. The validation results indicated this method was accurate (average inter/intra-day error, <10%), precise (inter/intra-day imprecision, <10%), and fast (10 min run time). In addition, time-consuming sample preparation was avoided applying dilute and shoot procedure, meeting the needs for potential large-scale population studies. The analysis of real samples demonstrated a pharmacokinetics of cannabinoids, their precursors and their metabolites dependent from quantity of carboxylated and decarboxylated compounds in pharmaceutical preparations.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biological fluids; Cannabinoids; Carboxylated and decarboxylated compounds; Medical cannabis; UHPLC-MS/MS

Mesh:

Substances:

Year:  2019        PMID: 31892011     DOI: 10.1016/j.talanta.2019.120537

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  6 in total

1.  Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review.

Authors:  Lourdes Poyatos; Ana Pilar Pérez-Acevedo; Esther Papaseit; Clara Pérez-Mañá; Soraya Martin; Olga Hladun; Adrià Siles; Marta Torrens; Francesco Paolo Busardo; Magí Farré
Journal:  Medicina (Kaunas)       Date:  2020-06-23       Impact factor: 2.430

Review 2.  Herbal Preparations of Medical Cannabis: A Vademecum for Prescribing Doctors.

Authors:  Pietro Brunetti; Simona Pichini; Roberta Pacifici; Francesco Paolo Busardò; Alessandro Del Rio
Journal:  Medicina (Kaunas)       Date:  2020-05-15       Impact factor: 2.430

3.  Disposition of Phytocannabinoids, Their Acidic Precursors and Their Metabolites in Biological Matrices of Healthy Individuals Treated with Vaporized Medical Cannabis.

Authors:  Francesco Paolo Busardò; Ana Pilar Pérez-Acevedo; Roberta Pacifici; Giulio Mannocchi; Massimo Gottardi; Esther Papaseit; Clara Pérez-Mañá; Soraya Martin; Lourdes Poyatos; Simona Pichini; Magí Farré
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-13

Review 4.  Pharmacokinetics of Cannabis and Its Derivatives in Animals and Humans During Pregnancy and Breastfeeding.

Authors:  Anaëlle Monfort; Ema Ferreira; Grégoire Leclair; Gregory Anton Lodygensky
Journal:  Front Pharmacol       Date:  2022-07-12       Impact factor: 5.988

5.  Acute Pharmacological Effects and Oral Fluid Biomarkers of the Synthetic Cannabinoid UR-144 and THC in Recreational Users.

Authors:  Nunzia La Maida; Esther Papaseit; Lucia Martínez; Clara Pérez-Mañá; Lourdes Poyatos; Manuela Pellegrini; Simona Pichini; Roberta Pacifici; Mireia Ventura; Liliana Galindo; Francesco Paolo Busardò; Magí Farré
Journal:  Biology (Basel)       Date:  2021-03-24

6.  UHPLC-MS/MS Analysis of Cannabidiol and Its Metabolites in Serum of Patients with Resistant Epilepsy Treated with CBD Formulations.

Authors:  Sara Malaca; Massimo Gottardi; Federica Pigliasco; Sebastiano Barco; Alessia Cafaro; Elisabetta Amadori; Antonella Riva; Martina Marcenaro; Pasquale Striano; Giuliana Cangemi; Roberta Pacifici; Simona Pichini; Francesco Paolo Busardò
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.